Crossmark

Clinical Studies of COMET for Total LSCD: a Review of the Methods and Molecular Markers for Follow-Up Characterizations

Published Online: 2021-01-22

Published Print: 2021-03

Authors

Attico, Eustachio https://orcid.org/0000-0001-9590-7630
Galaverni, Giulia

Pellegrini, Graziella
License Information

Text and Data Mining valid from 2021-01-22

Version of Record valid from 2021-01-22
More Information

Article History

Accepted: 28 December 2020

First Online: 22 January 2021

Compliance with Ethical Standards

:

: Dr. Eustachio Attico and Dr. Giulia Galaverni declare no conflict of interest. Prof. Graziella Pellegrini is a member of the Board of Directors, R&D Director of Holostem Terapie Avanzate, and J-TEC consultant.

: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).

Document is current